Oclacitinib Tablet

23 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

430.0%

Death Rate

Active Ingredients

Oclacitinib Tablet

Administration Routes

OralUnknown

Species Affected

Dog 22

Cat 1

Most Affected Breeds

Terrier - Yorkshire 4

Retriever - Labrador 3

Retriever - Golden 2

Shepherd Dog - German 1

Bullmastiff 1

Chihuahua 1

Domestic Shorthair 1

Collie - Border 1

Pit Bull 1

Dachshund - Miniature 1

Most Reported Reactions

Pruritus 5

Vomiting 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Underdose 3

Skin lesion NOS 3

Lack of efficacy (ectoparasite) - flea 3

Diarrhoea 2

Elevated serum alkaline phosphatase (SAP) 2

Other abnormal test result NOS 2

Hyperkalaemia 2

Thrombocytosis 2

Panting 2

Outcome Breakdown

Outcome Unknown

12 (52.2%)

Recovered/Normal

8 (34.8%)

Ongoing

2 (8.7%)

Died

1 (4.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.